Evidence map›Paper›PMID 32921733›Full record

ReviewActa bio-medica : Atenei Parmensis2020

Vaccine hesitancy in COVID-19 times. An update from Italy before flu season starts.

Anna Odone, Daria Bucci, Roberto Croci, Matteo Riccò, Paola Affanni, Carlo Signorelli

Abstract readReview
In one paragraph

Review in Acta bio-medica : Atenei Parmensis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Undergraduate Vaccine Hesitancy and the Influence of "Home" Locales.International journal of environmental research and public health · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna OdoneSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy. odone.anna@hsr.it.
Daria BucciSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Bucci.daria@hsr.it.
Roberto CrociSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy. croci.roberto@hsr.it.
Matteo RiccòUniversity of Parma, Parma, Italy. mricco2000@gmail.com.
Paola AffanniAUSL Reggio Emilia, Reggio Emilia, Italy. paola.affanni@unipr.it.
Carlo SignorelliSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy; University of Parma, Parma, Italy. carlo.signorelli@unipr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic and response caused a worrying decline in vaccine uptake around the world. In Italy, the immunization coverage targets set in the 2017-19 National Immunization Prevention Plan (PNPV) have been met only partially. The current public health emergency is likely to have negatively impacted on immunization , with the risk of re-occurrence of Vaccine-Preventable Diseases (VPDs) outbreaks. As flu season approaches, both National Health Institutions  and the scientific community in Italy have taken action. Well in advance as compared to previous years, the Ministry of Health released  the Circular to launch the 2020-2021 influenza immunization campaign which this year is longer (starting on October 2020) and extends flu vaccine recommendations to more  "at risk" subgroups, offered the vaccine free of charge. In addition, some Italian Regions have recently tried to make  flu vaccination compulsory for all Healthcare Workers (HCWs). Since 2017, when the law on childhood vaccination in Italy was passed, compulsory vaccination has proved to be a successful strategy towards coverage increase.

Indexed as

BetacoronavirusAlphainfluenzavirusComorbidityCoronavirus InfectionsCOVID-19Global HealthHealth PersonnelHumansInfluenza, HumanInfluenza VaccinesPandemicsPneumonia, ViralSARS-CoV-2VaccinationInfluenza Vaccines

Identifiers

PMID32921733
PMCPMC7716975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.